Aromatase inhibitors for subfertile women with polycystic ovary syndrome
Referencias
Additional references
Abu Hashim H. Clomiphene citrate alternatives for the initial management of polycystic ovary syndrome: an evidence‐based approach. Archives of Gynecology and Obstetrics 2012;285:1737‐45.
Baruah J, Roy KK, Rahman SM, Kumar S, Sharma JB, Karmakar D. Endometrial effects of letrozole and clomiphene citrate in women with polycystic ovary syndrome using spiral artery Doppler. Archives of Gynecology and Obstetrics 2009;279:311‐4.
Biljan MM, Hemmings R, Brassard N. The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertility and Sterility 2005;84:(suppl 1):S95.
Julie Brown, Cindy Farquhar, James Beck, Clare Boothroyd, Edward Hughes. Clomiphene and anti‐oestrogens for ovulation induction in PCOS. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD002249.pub4]
Casper RF, Mitwally MF. Review: aromatase inhibitors for ovulation induction. Journal of Clinical Endocrinology & Metabolism 2006;91:760‐71.
Casper, RF, Mitwally, MF. Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome. Clinical Obstetrics and Gynaecology 2011;54:685‐95.
Cole PA, Robinson CH. Mechanism and inhibition of cytochrome P‐450 aromatase. Journal of Medical Chemistry 1990;33:2933‐2944.
Farquhar CM, Williamson K, Gudex G, Johnson NP, Garland J, Sadler L. A randomized controlled trial of laparoscopic ovarian diathermy versus gonadotropin therapy for women with clomiphene citrate‐resistant polycystic ovary syndrome. Fertility and Sterility 2002;78(2):404.
Forman R, Gill S, Moretti M, Tulandi T, Koren G, Casper R. Fetal safety of letrozole and clomiphene citrate for ovulation induction. Journal of obstetrics and gynaecology Canada 2007;29(8):668‐71.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Jirge PR, Patil RS. Comparison of endocrine and ultrasound profiles during ovulation induction with clomiphene citrate and letrozole in ovulatory volunteer women. Fertility and Sterility 2010;93:174‐83.
Lee VC, Ledger W. Aromatase inhibitors for ovulation induction and ovarian stimulation. Clinical Endocrinology 2011;74:537‐46.
Lunenfeld, B. Historical perspectives in gonadotrophin therapy. Human Reproduction Update 2004;10:453.
Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertility and Sterility 2001;75:305‐9.
Rotterdam ESHRE/ASRM‐Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long‐term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 2004;19(1):41.
Samani FG, Farzadi L, Nezami N, Tarzamni MK, Soleimani F. Endometrial and follicular development following letrozole intervention in unexplained infertile patients failed to get pregnant with clomiphene citrate. Archives of Gynecology and Obstetrics 2009;280:201‐5.
Tulandi T, Martin J, Al‐Fadhli R, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertility and Sterility 2006;85:1761‐5.
Velázquez E, Acosta A, Mendoza SG. Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstetrics and Gynecology 1997;90(3):392.
White DM, Polson DW, Kiddy D, Sagle P, Watson H, Gilling‐Smith C, et al. Induction of ovulation with low‐dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. Journal of Clinical Endocrinology & Metabolism 1996;81(11):3821.
